Friday, 2 December 2016

First-in-class asthma treatment gets provisional green light

NICE recommends mepolizumab for severe and troubling eosinophilic disease

Related items from OnMedica

The challenges of asthma
Childhood asthma overdiagnosed, warn respiratory doctors
Asthma costs UK health service at least £1bn every year
Vitamin D supplements reduce severe asthma attacks
Hospital discharge of children following asthma attack needs improvement
via OnMedica News Read More Here.. Lake forest health and fitness http://ift.tt/2gIw9JV

No comments:

Post a Comment